Search results
Results From The WOW.Com Content Network
Regression diagnostics have often been developed or were initially proposed in the context of linear regression or, more particularly, ordinary least squares. This means that many formally defined diagnostics are only available for these contexts.
The company was founded in 1976 by Roger C. Lucas as Research and Diagnostic Systems, Inc. In 1985, it merged into Techne Corporation and became a public company. [1] In March 2013, Charles (Chuck) Kummeth was named chief executive officer of the company. [2] In July 2013, the company acquired Bionostics for $104 million. [3] [4]
The Zimmermann reagent is used as a simple spot-test used in chromatography to presumptively identify alkaloids, especially benzodiazepines, as well as other compounds.It is therefore used in drugs testing.
Computer-aided detection (CADe), also called computer-aided diagnosis (CADx), are systems that assist doctors in the interpretation of medical images.Imaging techniques in X-ray, MRI, endoscopy, and ultrasound diagnostics yield a great deal of information that the radiologist or other medical professional has to analyze and evaluate comprehensively in a short time.
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States , Puerto Rico , Mexico , and Brazil . [ 3 ] Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Creative Diagnostics was founded in Shirley, New York, USA in 2005.Originally, the business was focused on monoclonal and polyclonal antibodies. [3] [4] Later, various kinds of antibodies, viral antigens, reagents, medical kits, and biological services were launched to broaden the company's activities.
Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer.
FIND (Foundation for Innovative New Diagnostics) is a global health non-profit based in Geneva, Switzerland. FIND functions as a product development partnership, engaging in active collaboration with over 150 partners to facilitate the development, evaluation, and implementation of diagnostic tests for poverty-related diseases.